title: Application of a medicolegal approach in clinical stalemates.
authors.affiliation: Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA. michael.tang@yale.edu
authors.forename: Michael
authors.initials: M
authors.lastname: Tang
mesh_terms: D000208:Acute Disease; D002545:Brain Ischemia / Q000150:complications; D004363:Drug Utilization / Q000941:ethics / Q000331:legislation & jurisprudence* / Q000592:standards / Q000639:trends; D004636:Emergency Service, Hospital / Q000941:ethics / Q000331:legislation & jurisprudence* / Q000592:standards / Q000639:trends; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D019983:Guideline Adherence / Q000941:ethics / Q000331:legislation & jurisprudence* / Q000592:standards / Q000639:trends; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007258:Informed Consent; D016365:Liability, Legal; D010820:Physicians / Q000941:ethics / Q000331:legislation & jurisprudence*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic / Q000941:ethics / Q000331:legislation & jurisprudence; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology; D000077785:Tenecteplase; D057212:Therapeutic Equipoise; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects; D014481:United States
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase